• Rapid test Supplier
  • Rapid Influenza A/B Antigen Test Kit | Fast & Accurate Diagnostic Solution

Jul . 20, 2025 21:33 Back to list

Rapid Influenza A/B Antigen Test Kit | Fast & Accurate Diagnostic Solution

Gaobeidian PRISES Biotechnology Co., Ltd

Global leader in rapid diagnostic solutions

Phone

0086-(0)312-2930588

Email

export@prises.cn

Mobile

0086-15910623759

Address

No.136, Shiji West Road, Gaobeidian City, 074000, Hebei Province, P.R. China

Visit Our Website

Product Overview

The Flu A B Influenza Virus Ag Diagnostic Rapid Test Kit is an in vitro diagnostic test utilizing immunochromatographic technology. Designed for qualitative determination of influenza type A and type B virus infection, this test delivers results in just 8 minutes using nasopharyngeal swab specimens from symptomatic patients.

As the demand for accurate influenza a/b antigen test solutions grows worldwide, our influenza a/b antigen test kit provides healthcare professionals with a reliable tool for rapid diagnosis. The importance of distinguishing between Influenza A and B strains is critical for appropriate patient management and epidemiological surveillance.

Learn More About Our Product

Industry Trends & Market Analysis

The global market for rapid influenza diagnostic tests is experiencing substantial growth, with an estimated CAGR of 6.8% from 2023 to 2030. This expansion is driven by increased influenza prevalence, technological advancements in test kits, and growing awareness of early diagnosis.

Our Flu A B Influenza Virus Ag Diagnostic Rapid Test Kit is developed in response to the increasing need for point-of-care testing solutions that deliver laboratory-quality results in clinical settings, pharmacies, and even at home.

Technical Specifications & Performance Data

Understanding the technical parameters is essential for selecting the right diagnostic solution. Our influenza a/b antigen test kit offers exceptional performance metrics:

Performance Comparison

Parameter Our Product Industry Average
Detection Time 8 minutes 10-15 minutes
Sensitivity (Influenza A) 96.4% 90-95%
Sensitivity (Influenza B) 95.2% 88-94%
Specificity (Overall) 98.7% 96-98%
Storage Temperature 2-30°C 2-8°C
Sample Type Nasopharyngeal Swab Varies

Application Scenarios

The Flu A B Influenza Virus Ag Diagnostic Rapid Test Kit is designed for versatility across multiple healthcare settings:

Hospital Settings

Emergency departments utilize our influenza a/b antigen test for rapid triage of patients with influenza-like symptoms, enabling appropriate isolation decisions and treatment plans.

Clinics & Outpatient

Primary care physicians benefit from immediate results that inform antiviral prescription decisions during peak influenza seasons.

Long-Term Care

Nursing homes use our tests for early detection and containment of outbreaks among vulnerable populations.

School Health Programs

Educational institutions implement our influenza a/b antigen test kit for rapid screening to minimize absenteeism.

Professional FAQ

Q: What are the key components included in the Flu A B Influenza Virus Ag Diagnostic Rapid Test Kit?

A: Our test kit contains test cassettes, disposable sterile swabs, extraction buffer tubes, tube holders, and comprehensive instructions. Each component is quality-controlled for maximum reliability.

Q: How should I store the test kit to maintain its effectiveness?

A: Store the unopened kit at 2-30°C in a dry environment. Avoid freezing and exposure to direct sunlight. The kit remains stable for 24 months from the manufacturing date when properly stored.

Q: What is the scientific principle behind this influenza rapid test?

A: The test uses colloidal gold immunochromatography. The test strip contains monoclonal antibodies specific to influenza A and B nucleoproteins. When viral antigens are present, they bind to gold-conjugated antibodies and form visible lines on the membrane.

Q: How do you ensure quality control in manufacturing?

A: We implement a rigorous multi-stage QC process: raw material screening, in-process controls, and final product validation. Each batch undergoes performance testing against reference samples to ensure clinical accuracy.

Q: Is special training required to administer this test?

A: The test is designed for CLIA-waived complexity. Healthcare professionals can perform it after reviewing the included instructions. We also provide online training resources through our website.

Q: How does this influenza test handle emerging viral strains?

A: Our antibody selection targets highly conserved viral regions. We continuously monitor circulating strains and update our antigen targets when necessary. This commitment ensures sustained detection performance.

Q: What is the clinical significance of distinguishing Influenza A from B?

A: While treatment protocols are similar, distinguishing the type has epidemiological importance and can inform prognosis. Influenza A is associated with greater severity and pandemic potential, while Influenza B typically causes milder but more prolonged symptoms.

References & Expert Endorsements

The clinical value of rapid influenza diagnostic tests has been validated in numerous peer-reviewed studies:

Share

Next:

This is the last article

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


suSundanese